Selection of N86F184D1246 haplotype of Pfmrd1 gene by artemether–lumefantrine drug pressure on Plasmodium falciparum populations in Senegal

[1]  B. Ogutu,et al.  Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether–lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya , 2015, International journal for parasitology. Drugs and drug resistance.

[2]  B. Pradines,et al.  Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013–2014 malaria season , 2015, Malaria Journal.

[3]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[4]  M. Alifrangis,et al.  Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania , 2014, Malaria Journal.

[5]  C. Rogier,et al.  The rise and fall of malaria in a West African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study. , 2014, The Lancet. Infectious diseases.

[6]  J. Ndiaye,et al.  Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance , 2013, BMC Infectious Diseases.

[7]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[8]  O. Ndir,et al.  Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal , 2013, Malaria Journal.

[9]  Saorin Kim,et al.  Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. , 2013, The Lancet. Infectious diseases.

[10]  O. Ndir,et al.  Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal☆ , 2013, International journal for parasitology. Drugs and drug resistance.

[11]  D. Ménard,et al.  Étude de la résistance de Plasmodium falciparum aux antipaludiques au sein du réseau international des Instituts Pasteur (RIIP-Palu) , 2013 .

[12]  N. Waters,et al.  The Role of Pfmdr1 and Pfcrt in Changing Chloroquine, Amodiaquine, Mefloquine and Lumefantrine Susceptibility in Western-Kenya P. falciparum Samples during 2008–2011 , 2013, PloS one.

[13]  J. Lampe.  Case Studies in Modern Drug Discovery and Development , 2013 .

[14]  Saorin Kim,et al.  Reduced Artemisinin Susceptibility of Plasmodium falciparum Ring Stages in Western Cambodia , 2012, Antimicrobial Agents and Chemotherapy.

[15]  J. Ndiaye,et al.  Assessment of the Molecular Marker of Plasmodium falciparum Chloroquine Resistance (Pfcrt) in Senegal after Several Years of Chloroquine Withdrawal , 2012, The American journal of tropical medicine and hygiene.

[16]  O. Sarr,et al.  Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8 years after cessation of chloroquine use in Pikine, Senegal , 2012, Parasitology Research.

[17]  Xianhai Huang,et al.  Case Studies in Modern Drug Discovery and Development: Huang/Case Studies Drug Discovery , 2012 .

[18]  Pardis C Sabeti,et al.  Rapid, Field-Deployable Method for Genotyping and Discovery of Single-Nucleotide Polymorphisms Associated with Drug Resistance in Plasmodium falciparum , 2012, Antimicrobial Agents and Chemotherapy.

[19]  P. Rosenthal,et al.  Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda. , 2011, The Journal of infectious diseases.

[20]  C. Rogier,et al.  La résistance aux antipaludiques , 2010 .

[21]  J. Ndiaye,et al.  Efficacy and tolerability of artesunate‐amodiaquine (Camoquin plus®) versus artemether‐lumefantrine (Coartem®) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast , 2010, Tropical medicine & international health : TM & IH.

[22]  J. Daily,et al.  A non-radioactive DAPI-based high-throughput in vitro assay to assess Plasmodium falciparum responsiveness to antimalarials--increased sensitivity of P. falciparum to chloroquine in Senegal. , 2010, The American journal of tropical medicine and hygiene.

[23]  J. Ndiaye,et al.  Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria , 2009, Malaria Journal.

[24]  Z. Premji,et al.  In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. , 2009, The Journal of infectious diseases.

[25]  D. Wirth,et al.  Selection of Plasmodium falciparum Multidrug Resistance Gene 1 Alleles in Asexual Stages and Gametocytes by Artemether-Lumefantrine in Nigerian Children with Uncomplicated Falciparum Malaria , 2008, Antimicrobial Agents and Chemotherapy.

[26]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[27]  P. Rosenthal,et al.  Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children , 2008, Malaria Journal.

[28]  S. Krishna,et al.  The role of pfmdr1 in Plasmodium falciparum tolerance to artemether‐lumefantrine in Africa , 2007, Tropical medicine & international health : TM & IH.

[29]  Georgina S. Humphreys,et al.  Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of the Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated Malaria , 2006, Antimicrobial Agents and Chemotherapy.

[30]  T. Anderson,et al.  The origins and spread of antimalarial drug resistance: lessons for policy makers. , 2005, Acta tropica.

[31]  B. Pradines,et al.  In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents. , 1998, The Journal of antimicrobial chemotherapy.

[32]  S. Grate,et al.  Fatal neurotoxicity of arteether and artemether. , 1994, The American journal of tropical medicine and hygiene.

[33]  H. S. Gill,et al.  CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN SEMI-IMMUNE NATIVE AFRICAN TANZANIANS , 1982, The Lancet.

[34]  F. Naeim,et al.  Letter: HL-A antigens in myasthenia gravis. , 1974, Lancet.

[35]  R. Blount.  Management of chloroquine-resistant falciparum malaria. , 1967, Archives of internal medicine.

[36]  Frédéric Ariey.  Étude de la résistancePlasmodium falciparum antipaludiques au sein du réseau international des Instituts Pasteur , 2013 .

[37]  P. Roepe,et al.  A single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform. , 2008, Molecular and biochemical parasitology.